FIFA president Gianni Infantino’s remodeling of the Club World Cup marks a new low in placing financial demands over basic ...

Cytokinetics (CYTK) and Bayer (BAYRY) announced they have entered into a collaboration and license agreement for the exclusive development and ...

Bayer is now going to conduct Phase 3 clinical trials for obstructive HCM in Japan, while Cytokinetics will expand its ongoing ACACIA-HCM and CEDAR-HCM trials into Japan.

FRANKFURT (Reuters) - Bayer on Tuesday struck a collaboration deal with U.S. biotech firm Cytokinetics to acquire certain ...

Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today revealed its 2024 list of Highly ...

Approximately €70 Million in Upfront and Near-term Payments to CytokineticsUp to €490 Million in Commercial Milestone Payments, withTiered ...